ArriVent BioPharma
AVBP
AVBP
68 hedge funds and large institutions have $612M invested in ArriVent BioPharma in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
12.48% more ownership
Funds ownership: 64.66% → 77.13% (+12%)
Holders
68
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$29.8M | |
| 2 | +$16.3M | |
| 3 | +$8.51M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.59M |
| 5 |
Millennium Management
New York
|
+$4.81M |
Top Sellers
| 1 | -$1.67M | |
| 2 | -$689K | |
| 3 | -$464K | |
| 4 |
Jane Street
New York
|
-$111K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$30.8K |